BIOTECHNOLOGICAL INTERVENTIONS FOR ENHANCED SECONDARY METABOLITE PRODUCTION IN MEDICINAL PLANTS
DOI:
https://doi.org/10.29121/granthaalayah.v13.i7.2025.6414Keywords:
Medicinal Plants, Secondary Metabolites, Biotechnology, Metabolic Engineering, Hairy Root Culture, Crispr/Cas9, OmicsAbstract [English]
Medicinal plants are rich repositories of secondary metabolites such as alkaloids, flavonoids, terpenoids, glycosides, and phenolics that serve as essential raw materials for pharmaceuticals, nutraceuticals, and cosmetic industries. However, their natural accumulation in planta is often insufficient, inconsistent, and subject to environmental fluctuations, making large-scale production unsustainable. Biotechnological interventions provide innovative and sustainable solutions to enhance metabolite yield, improve quality, and ensure year-round availability.
This review highlights recent advancements in plant tissue culture systems (callus, suspension, and hairy root cultures), elicitor-based strategies, metabolic engineering, synthetic biology, and CRISPR/Cas9-mediated genome editing for enhancing metabolite productivity. The integration of omics platforms (genomics, transcriptomics, proteomics, and metabolomics) has enabled precise identification and regulation of key metabolic nodes. Case studies of Catharanthus roseus, Withania somnifera, and Artemisia annua are discussed to illustrate real-world applications.
Although remarkable progress has been made, challenges remain, including pathway complexity, high cost of in vitro systems, and regulatory hurdles for genetically engineered plants. The article concludes that combining traditional knowledge with modern biotechnology and systems biology will accelerate the industrial-scale production of bioactive compounds, ensuring global healthcare sustainability.
Downloads
References
Giri, A., & Narasu, M. L. (2000). Transgenic Hairy Roots: Recent Trends and Applications. Biotechnology Advances, 18(1), 1–22. https://doi.org/10.1016/S0734-9750(99)00016-6 DOI: https://doi.org/10.1016/S0734-9750(99)00016-6
Li, M., Zhang, C., Xu, J., Shi, Y., & Yang, X. (2017). CRISPR/Cas9-Mediated Gene Editing in Medicinal Plants. Plant Cell Reports, 36(10), 1447–1456. https://doi.org/10.1007/s00299-017-2202-4 DOI: https://doi.org/10.1007/s00299-017-2202-4
Murashige, T., & Skoog, F. (1962). A Revised Medium for Rapid Growth and Bioassays with Tobacco Tissue Cultures. Physiologia Plantarum, 15(3), 473–497. https://doi.org/10.1111/j.1399-3054.1962.tb08052.x DOI: https://doi.org/10.1111/j.1399-3054.1962.tb08052.x
Van der Heijden, R., Jacobs, D. I., Snoeijer, W., Hallard, D., & Verpoorte, R. (2004). The Catharanthus Alkaloids: Pharmacognosy and Biotechnology. Current Medicinal Chemistry, 11(5), 607–628. https://doi.org/10.2174/0929867043455846 DOI: https://doi.org/10.2174/0929867043455846
Verpoorte, R., Contin, A., & Memelink, J. (2002). Biotechnology for the Production of Plant Secondary Metabolites. Phytochemistry Reviews, 1, 13–25. https://doi.org/10.1023/A:1015871916833 DOI: https://doi.org/10.1023/A:1015871916833
Zhang, Y., Nowak, G., & Reed, D. W. (2011). Engineering Artemisinin Biosynthesis in Artemisia Annua. Plant Biotechnology Journal, 9(5), 484–494. https://doi.org/10.1111/j.1467-7652.2011.00583.x
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr. Ragini Sikarwar
This work is licensed under a Creative Commons Attribution 4.0 International License.
With the licence CC-BY, authors retain the copyright, allowing anyone to download, reuse, re-print, modify, distribute, and/or copy their contribution. The work must be properly attributed to its author.
It is not necessary to ask for further permission from the author or journal board.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
